1)HaploidenticalHLA半相合
1.Preliminary Observation on Antitumor Effect of IL-2 Activated HLA Haploidentical Allogenic Peripheral Blood Monocular Cells in Treatment of Metastatic or Chemo-resistant Solid Tumor;IL-2短期活化的HLA半相合的外周血单个核细胞治疗晚期恶性实体瘤初步观察
2.Part I: Observation on antitumor effect of mobilizing activated related HLA-haploidentical allogenic mononuclear cells in treatment of the metastatic or chemoresistant solid tumor patientsobjective To study the feasibility of activated related HLA-haploidentical allogenic monocytes in treatment of the metastatic or chemoresistant solid tumor patients.第—部分:活化动员的亲缘间HLA半相合异基因单个核细胞治疗晚期转移或化疗抵抗性 实体瘤初步观察 目的:初步探讨活化动员的亲缘间HLA半相合异基因单个核细胞治疗晚期转移性/化疗抗性实体瘤的可行性。
英文短句/例句
1.The Clinical Study of HLA-haploidentical Lymphocyte Infusions for 59 Patients with Refractory Solid TumorsHLA半相合淋巴细胞输注治疗59例难治性实体瘤的临床分析
2.Clinical study on transplantation of HLA haploidentical stem cell for the treatment of leukemia亲缘HLA半相合造血干细胞移植治疗白血病10例临床分析
3.Anti-tumor and immunoregulatory activities of activated HLA haploidentical hematopoietic stem cellsHLA半相合的活化造血干细胞的抗肿瘤及免疫调节作用
4.Experimental and Clinical Study on Efficacy of Activated HLA Haploidentical Peripheral Blood Stem Cells Against Advanced Intractable Solid Tumor活化的HLA半相合外周血干细胞治疗晚期难治性实体瘤的基础和临床实验研究
5.Clinical Study of HLA Partially Mismatched Peripheral Blood Stem Cell Transplantation from Relative Donors for Treatment of Acute Leukemia亲缘间HLA半相合外周血造血干细胞移植治疗急性白血病的临床研究
6.Prediction of HLA-A* 0201-binding peptides of HBV related proteins using integrated method整合法预测HBV相关抗原的HLA-A* 0201限制性结合肽
7.Donors of HLA 1/6-2/6 mismatch were accepted at registry search.多份移植脐血HLA匹配为16-26位点不相合。
8.Analysis Association between HLA-DRB_1、 DQB_1 Gene and Pulmonary Tuberculosis Complicated with Diabetes Mellitus;HLA-DRB_1和DQB_1基因与肺结核合并溏尿病相关性分析
9.Observation and nursing care of patients with hemorrhagic cystitis after underwent HLA non-matched fully bone marrow transplantationHLA不相合骨髓移植术后出血性膀胱炎的观察和护理
10.Relationship between the Genetic Background of Donor KIR-recipient HLA and the Outcomes in HLA-identical Sibling HSCT;供者KIR和受者HLA遗传背景与亲缘全相合HSCT预后的关系
11.Transfusion of partially HLA-matched irradiated allogeneic blood mononuclear cells for advanced renal-cell carcinoma输注经照射的HLA部分相合的异基因单个核细胞治疗晚期肾细胞癌
12.Clinical study on haploid HLA-haploidentical hematopoietic stem cell transplantation for treatment of malignant hematological diseaseHLA单倍相合造血干细胞移植治疗恶性血液病的临床研究
13.The Study of the Relativity between Eales Disease and HLA-DRB, HLA-DQB1 Alleles;HLA-DRB及HLA-DQB1等位基因与Eales病相关性研究
14.The Design and Implementation of Semi Physisycal Simulation System Based on HLA;基于HLA半实物仿真系统的设计与实现
15.Comparison of Clinical Outcome between HLA Allele Matched and 1-2 Alleles Disparity Unrelated Donor Bone Marrow Transplantation;HLA基因位点全相合和1～2个基因位点不合非亲缘异基因骨髓移植的临床疗效比较
16.Changes of Lymphocyte Subsets in Acute Leukemia Patients after HLA-mismatched Nonmyeloablative Hematopoietic Stem Cell Transplantation急性白血病患者HLA不全相合非清髓造血干细胞移植后淋巴细胞亚群变化分析
17.Impact of activating KIR on outcome of matched unrelated allo-hematopoietic stem cell transplantation激活性KIR受体在HLA全相合无关供体异基因造血干细胞移植中的作用
18.HLA-matched sibling donor allogeneic hematopoietic stem cell transplantation for treatment of chronic myeloid leukemia in 40 casesHLA相合同胞供者异基因造血干细胞移植治疗慢性粒细胞白血病40例
相关短句/例句
HLA haploidenticalHLA半相合
1.Clinical study on transplantation of HLA haploidentical stem cell for the treatment of leukemia亲缘HLA半相合造血干细胞移植治疗白血病10例临床分析
2.Objective:To study the antineoplasmic activity and mechanism of action of activated HLA haploidentical peripheral blood stem cells in vivo and in vitro,and further study the safety and feasibility in treatment of advanced intractable solid tumor patients.目的:初步探讨活化的HLA半相合外周血干细胞(haplo-PBSCs)在体内外的抗肿瘤活性和作用机制,评价其治疗晚期难治性实体瘤的安全性和可行性,并分析影响其治疗效果的相关因素,以期为晚期难治性实体瘤患者提供一条新的安全的异体免疫治疗途径。
3)HLA-haploidenti-cal transplantationHLA-半相合
4)HLA mismatchHLA不相合
1.Objective: To explore the feasibility of HLA mismatched hemopietic stem cell transplants for the treatment of leukemia.方法 :总结我所于 2 0 0 0年 7月至 2 0 0 1年 12月进行的 7例HLA不相合造血干细胞移植 ,其中包括 3例慢性髓性白血病、3例急性非淋巴细胞性白血病、1例急性淋巴细胞白血病。
5)HLA matchedHLA全相合
1.24 patients with various hematologic malignancies recieved PBSCT/BMT from their HLA matched or unrelated donors and haploidentical siblings in April-December 2007.24例不同血液病患者接受HLA全相合同胞、非血缘供者或单倍体相合同胞造血干细胞移植。
6)HLA non-identicalHLA不全相合
1.HLA non-identical allogeneic peripheral blood hematopoietic stem cell transplantation for severe aplastic anemia;HLA不全相合异基因外周血干细胞移植治疗重型再生障碍性贫血
延伸阅读
HLA分子式：CAS号：性质：一个复杂的抗原群，决定了人类组织的组织配伍性，正如ABO血型抗原决定了输血的配伍性一样。
